Zevra Therapeutics (ZVRA) Operating Income Growth (5y) (2019 - 2026)
Zevra Therapeutics (ZVRA) Operating Income Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Zevra Therapeutics | 562.16 Mn | 361.54 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.60% |
| Dec 31, 2025 | 37.41% |
| Sep 30, 2025 | 40.19% |
| Jun 30, 2025 | -96.63% |
| Mar 31, 2025 | -7.27% |
| Dec 31, 2024 | -28.44% |
| Sep 30, 2024 | -59.87% |
| Jun 30, 2024 | -25.02% |
| Mar 31, 2024 | -12.50% |
| Dec 31, 2023 | -10.34% |
| Sep 30, 2023 | 3.07% |
| Jun 30, 2023 | 14.78% |
| Mar 31, 2023 | 2.77% |
| Dec 31, 2022 | -2.70% |
| Sep 30, 2022 | 7.17% |
| Jun 30, 2022 | -24.67% |
| Dec 31, 2021 | 23.48% |
| Sep 30, 2021 | 26.56% |
| Jun 30, 2021 | 21.33% |
| Mar 31, 2021 | 24.56% |